Literature DB >> 34320129

Pre- and post-COVID-19 evaluation of antimicrobial susceptibility for healthcare-associated infections in the intensive care unit of a tertiary hospital.

Gilberto Gambero Gaspar1,2, Lécio Rodrigues Ferreira2, Cinara Silva Feliciano2, Cláudio Penido Campos Júnior2, Fabiana Murad Rossin Molina2, Andrea Cristina Soares Vendruscolo2, Giovana Marcão Araújo Bradan2, Nátali Artal Padovani Lopes2, Roberto Martinez1, Valdes Roberto Bollela1.   

Abstract

INTRODUCTION: Antimicrobial resistance has worsened since the onset of COVID-19.
METHODS: This study involved patients admitted to the adult intensive care unit (ICU) of a tertiary hospital. Pre- and post-COVID-19 data were analyzed. The healthcare-related infections (HCRIs) reported between January 2018 and January 2020 and during the pandemic between February and July 2020 were compared.
RESULTS: Antimicrobial resistance increased during the pandemic, especially for Klebsiella pneumoniae isolates, with a rate increase from 5% to 50% for Polymyxin B.
CONCLUSIONS: The susceptibilities of the main pathogens associated with HCRIs in the ICU changed and should be considered in managing severe COVID-19.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34320129     DOI: 10.1590/0037-8682-0090-2021

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

1.  Antibiotic Resistance Patterns and Association With the Influenza Season in the United States: A Multicenter Evaluation Reveals Surprising Associations Between Influenza Season and Resistance in Gram-Negative Pathogens.

Authors:  Vikas Gupta; Kalvin C Yu; Heidi Kabler; Janet A Watts; Amine Amiche
Journal:  Open Forum Infect Dis       Date:  2022-01-25       Impact factor: 3.835

2.  Nosocomial Outbreak of Extensively Drug-Resistant (Polymyxin B and Carbapenem) Klebsiella pneumoniae in a Collapsed University Hospital Due to COVID-19 Pandemic.

Authors:  Gilberto G Gaspar; Gustavo Tamasco; Nathália Abichabki; Ana Flavia T Scaranello; Maria Auxiliadora-Martins; Renata Pocente; Leonardo N Andrade; María-Eugenia Guazzaroni; Rafael Silva-Rocha; Valdes R Bollela
Journal:  Antibiotics (Basel)       Date:  2022-06-17

3.  Impact of an antimicrobial stewardship program in a COVID-19 reference hospital according to the AWaRe classification.

Authors:  Joao Paulo Telles; Carolina Hikari Yamada; Thayrine Mayara Dario; Alexia Nascimento Miranda; Alceu Pacheco; Felipe Francisco Tuon
Journal:  Am J Infect Control       Date:  2022-07-22       Impact factor: 4.303

4.  The impact of COVID-19 on antimicrobial prescription and drug resistance in fungi and bacteria.

Authors:  Junya L Singulani; Danielle L Silva; Caroline M Lima; Vanessa C R Magalhães; Ludmila M Baltazar; Nalu T A Peres; Rachel B Caligiorne; Alexandre S Moura; Ana Raquel O Santos; Tatiani Fereguetti; Juliana C Martins; Lívia F Rabelo; Ana C Lyon; Susana Johann; Juliana P Falcão; Daniel A Santos
Journal:  Braz J Microbiol       Date:  2022-09-10       Impact factor: 2.214

Review 5.  Antibiotic Resistance during COVID-19: A Systematic Review.

Authors:  Hadi Jaber Al Sulayyim; Rohani Ismail; Abdullah Al Hamid; Noraini Abdul Ghafar
Journal:  Int J Environ Res Public Health       Date:  2022-09-21       Impact factor: 4.614

Review 6.  Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.

Authors:  Huan-Yi Wu; Peng-Hao Chang; Kuan-Yu Chen; I-Fan Lin; Wen-Hsin Hsih; Wan-Lin Tsai; Jiun-An Chen; Susan Shin-Jung Lee
Journal:  J Microbiol Immunol Infect       Date:  2022-10-07       Impact factor: 10.273

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.